(NEW YORK)Shares of biotechnology company Amylin Pharmaceuticals Inc. jumped Monday following billionaire investor Carl Icahn's move to increase his ownership stake to 7.3 percent.READ MORE

(NEW YORK)Shares of several diabetes drug developers received a slight boost Tuesday as companies including Eli Lilly & Co. and Merck & Co. touted the effectiveness of their respective treat...READ MORE

(WASHINGTON)Danish drugmaker Novo Nordisk AS spent $350,000 lobbying the U.S. government in the second quarter, according to a recent disclosure report. The company lobbied on drug importation...READ MORE

(NEW YORK)Eli Lilly & Co. and Amylin Pharmaceuticals Inc. could feel more competitive pressure in the diabetes market as their drug Byetta comes under scrutiny after new patient deaths were ...READ MORE

(WASHINGTON)Eli Lilly and Amylin Pharmaceuticals Inc. on Tuesday reported four new deaths in patients taking Byetta, even as the companies tried to shore up the safety profile of their popular...READ MORE

(NEW YORK)Shares of drug developer Amylin Pharmaceuticals gained ground Monday following a sharp drop last week after the Food and Drug Administration said it is working on a stronger label ...READ MORE

(NEW YORK)Shares of drug developer Amylin Pharmaceuticals continued falling Thursday as safety concerns over its key diabetes drug continued to reverberate throughout the market.READ MORE